Next Article in Journal
The Role of Family Physicians in Cancer Care: Perspectives of Primary and Specialty Care Providers
Previous Article in Journal
The Two Solitudes of Primary Care and Cancer Specialist Care: Is There a Bridge?
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 24
Issue 2
10.3747/co.24.3644
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Clinician Participation in Cadth’s Pan-Canadian Oncology Drug Review: Contribution and Impact on Cancer Drug Funding Recommendations

by
M. Trudeau
1,
P. Hoskins
2,
T. Reiman
3,
A. Chambers
4,
H. Mai
4,* and
P. Wheatley-Price
5
1
Division of Medical Oncology and Hematology, Sunnybrook Odette Cancer Centre, Toronto, ON, Canada
2
Medical Oncology, BC Cancer Agency, Vancouver, BC, Canada
3
Department of Oncology, Saint John Regional Hospital, Saint John, NB, Canada
4
Pan-Canadian Oncology Drug Review, Canadian Agency for Drugs and Technologies in Health, Toronto, ON, Canada
5
Department of Medicine, The Ottawa Hospital and The Ottawa Hospital Research Institute, Ottawa, ON, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2017, 24(2), 71-74; https://doi.org/10.3747/co.24.3644
Submission received: 6 January 2017 / Revised: 5 February 2017 / Accepted: 5 March 2017 / Published: 1 April 2017

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

In any given week, media headlines publicize the benefits of a new “breakthrough” cancer drug, with patients and clinicians subsequently advocating for its use. [...]

Share and Cite

MDPI and ACS Style

Trudeau, M.; Hoskins, P.; Reiman, T.; Chambers, A.; Mai, H.; Wheatley-Price, P. Clinician Participation in Cadth’s Pan-Canadian Oncology Drug Review: Contribution and Impact on Cancer Drug Funding Recommendations. Curr. Oncol. 2017, 24, 71-74. https://doi.org/10.3747/co.24.3644

AMA Style

Trudeau M, Hoskins P, Reiman T, Chambers A, Mai H, Wheatley-Price P. Clinician Participation in Cadth’s Pan-Canadian Oncology Drug Review: Contribution and Impact on Cancer Drug Funding Recommendations. Current Oncology. 2017; 24(2):71-74. https://doi.org/10.3747/co.24.3644

Chicago/Turabian Style

Trudeau, M., P. Hoskins, T. Reiman, A. Chambers, H. Mai, and P. Wheatley-Price. 2017. "Clinician Participation in Cadth’s Pan-Canadian Oncology Drug Review: Contribution and Impact on Cancer Drug Funding Recommendations" Current Oncology 24, no. 2: 71-74. https://doi.org/10.3747/co.24.3644

Article Metrics

Back to TopTop